Court Keeps Hands Off Perrigo Tender; Under FTC Agreement, Mylan To Hand Off Ingredients
This article was originally published in The Tan Sheet
Executive Summary
If it brings Perrigo under its roof through a pending tender, Mylan agrees to divest its production of its drug ingredients that overlap with Perrigo’s. Additionally, litigation aimed at stalling the tender ends with neither firm convincing a judge that the other misled investors.
You may also be interested in...
Unilever Plan To Grow Consumer Health By Acquisition, Meet US Tightening Of Merger Scrutiny
Unilever, which has had three offers for GSK rebuffed, likely notes that the Federal Trade Commission and Department of Justice signal they will tighten scrutiny of deals that merge companies providing consumer-facing products and services.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.